Bone Marrow Grafting for Leukemia and Lymphoma

The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Leukemia Hematologic Diseases Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoma Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Stanford University School of Medicine

Stanford, California, 94305, United States

About this study

The purpose of this study is to acquire critical tissue and biological samples that can be evaluated to elucidate underlying mechanisms of disease control, transplant related complications and overall outcomes

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

- All hematopoietic cell transplant recipients and donors who agree to participate

Exclusion criteria

- Subject does not agree to participate

Treatment and study plan

collection and storage of tissue samples for research

Procedure

Tissue samples include blood draws for the donor and recipient. A bone marrow sample may be obtained from the recipient. If the recipient undergoes a tissue biopsy for clinical reasons, a small fraction may be removed for research purposes. A small fraction of the donor graft may be removed at the time of collection for research.

Primary outcomes

Identify and characterize proteins and genes that may contribute to the development and progression of cancer.

Time frame: blood sample is collected prior transplant, periodically during the first three months and then indefinately at follow up

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

National Cancer Institute (NCI)
National Institutes of Health (NIH)

Registry information

Important dates

Study start: 1988
Primary completion: 2069
Study completion: 2069
First posted: Sep 16, 2005
Registry last updated: Dec 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting